A preprint of the study by researchers of Oxford University noted that a third dose of the AstraZeneca vaccine will also lead to a substantial increase in immune response.
UK’s drug regulator is investigating rare cases of blood clots in adults who were given Oxford-AstraZeneca shot. No safety issues have arisen in children’s trial, Oxford says.
Amid reports that doses were causing blood clot-related complications, Johnson said that six months since its discovery, multiple countries like India are producing the vaccine.
According to Oxford University researchers, the first dose of the vaccine offers 76% protection, making it safe for the interval between doses to be extended to 3 months.
India’s vaccination strategy is smartly-designed and will strengthen healthcare workers to handle a second wave, says Dr V. Ravi, former basic sciences dean at NIMHANS.
Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.
While some Indians were spewing hatred, the government of Dubai got on with the job. The city coped with the crisis magnificently because of the quality of its leadership.
Major energy infrastructure is in the crosshairs of the conflict, raising risks of the biggest shock since Russia’s invasion of Ukraine. Qatar’s largest LNG plant remains shut, fuelling supply fears.
Sinking of the ship has raised eyebrows in the Indian defence and security establishment. Lankan navy has recovered several bodies, believed to be of crew members.
The Pakistani political leadership is weak and devoid of any intellect. Its diplomacy is entirely India-China-US focused and suffers from a presumptive view of Afghanistan as a vassal.
COMMENTS